HEPARIN SODIUM & 5% DEXTROSE INJECTION LIQ
HEPARIN SODIUM & 5% DEXTROSE INJECTION LIQ
Discontinued
DIN Number
02008181
Drug Class
Human
Market Date
Dec 31, 1992
Company
HC
baxter corporation
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02008181
AIG Number0220064003
Classification & Schedule
C
Drug Class
Human
S
Schedule
Ethical
A
ATC Code
B01AB51 HEPARIN, COMBINATIONS
Product Specifications
Dosage FormSolution
Route of AdministrationIntravenous
AHFS Classification20:12.04.16
Health Canada Classification
ACTIVE INGREDIENTS (2)
DEXTROSEActive
Strength: 5 G / 100 ML
Monograph: DEXTROSE
HEPARIN SODIUMActive
Strength: 10000 UNIT / 100 ML
Monograph: HEPARIN SODIUM